Imatinib buys time for brain after stroke

[1]  Ulf Eriksson,et al.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.

[2]  J. Arenillas,et al.  Influence of the stroke code activation source on the outcome of acute ischemic stroke patients , 2008, Neurology.

[3]  Markus Schwaninger,et al.  Improving Outcome after Stroke: Overcoming the Translational Roadblock , 2008, Cerebrovascular Diseases.

[4]  W. Hacke,et al.  Thrombolysis with alteplase for acute ischemic stroke: review of SITS-MOST and other Phase IV studies , 2007, Expert review of neurotherapeutics.

[5]  C. Fieber,et al.  Tissue plasminogen activator is a potent activator of PDGF‐CC , 2004, The EMBO journal.

[6]  D. Lawrence,et al.  Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. , 2003, The Journal of clinical investigation.

[7]  D. Holtzman,et al.  Role of Tissue Plasminogen Activator Receptor LRP in Hippocampal Long-Term Potentiation , 2000, The Journal of Neuroscience.

[8]  S. Lipton,et al.  Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.

[9]  J. Krupiński,et al.  A putative role for platelet-derived growth factor in angiogenesis and neuroprotection after ischemic stroke in humans. , 1997, Stroke.

[10]  S. Tsirka,et al.  An Extracellular Proteolytic Cascade Promotes Neuronal Degeneration in the Mouse Hippocampus , 1997, The Journal of Neuroscience.

[11]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[12]  J. Schellens,et al.  Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs. , 2006, Trends in pharmacological sciences.

[13]  Alain Buisson,et al.  The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling , 2001, Nature Medicine.